How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies
Abstract Programmed death ligand-1 (PD-L1) expression is a key biomarker to screen patients for PD-1/PD-L1-targeted immunotherapy. However, a subjective assessment guide on PD-L1 expression of tumor-infiltrating immune cells (IC) scoring is currently adopted in clinical practice with low concordance...
Guardado en:
Autores principales: | Xinran Wang, Liang Wang, Hong Bu, Ningning Zhang, Meng Yue, Zhanli Jia, Lijing Cai, Jiankun He, Yanan Wang, Xin Xu, Shengshui Li, Kaiwen Xiao, Kezhou Yan, Kuan Tian, Xiao Han, Junzhou Huang, Jianhua Yao, Yueping Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dcd2ce87231243738367b9b9bb95ee4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Artificial Intelligence Security in Multiple-Unmanned System Cooperation
por: Shi Wen, et al.
Publicado: (2021) -
Prediction of Shield Machine Attitude Based on Various Artificial Intelligence Technologies
por: Haohan Xiao, et al.
Publicado: (2021) -
Reliability and validity of the new Tanaka B Intelligence Scale scores: a group intelligence test.
por: Yota Uno, et al.
Publicado: (2014) -
Development of Content Security Based on Artificial Intelligence
por: Zhu Shiqiang, Wang Yongheng
Publicado: (2021) -
Automated tumor proportion score analysis for PD-L1 (22C3) expression in lung squamous cell carcinoma
por: Jingxin Liu, et al.
Publicado: (2021)